Wang Qi-Zhang, Zhao Ze-Liang, Liu Chao, Zheng Jia-Wei
Department of Oromaxillofacial Head and Neck Oncology, Shanghai Ninth People's Hospital, College of Stomatology, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Ann Transl Med. 2021 Mar;9(5):394. doi: 10.21037/atm-20-6456.
Though infantile hemangioma (IH) is a common benign vascular tumor, its pathogenesis remains unclear. This study explored the function of hemangioma-derived stem cells (HemSCs) derived exosomes, which exerted an intercellular effect on hemangioma-derived endothelial cells (HemECs).
First, HemSCs and HemECs were extracted and cultured. HemSCs derived exosomes (HemSCs-exos) were harvested. miRNA sequencing and target prediction were used to explore differentially expressed miRNAs and potential binding targets. After HemECs were co-cultured with HemSCs-exos, a series of assays were then performed including cell counting kit-8 (CCK-8) assay, cell apoptosis assay, cell cycle assay and tube formation assay to evaluate proliferation, angiogenesis abilities, etc. qRT-PCR and Western blot were conducted to detect the expression level of target genes and proteins.
After co-culturing with HemSCs-exos, proliferation, and angiogenesis abilities of HemECs were enhanced, while apoptosis and cell cycle arrest rate were decreased. MiR-196b-5p was observed to be significantly highly expressed in HemSCs-exos. CDKN1B was identified as the binding target of miR-196b-5p. HemECs' proliferation and angiogenesis abilities were elevated when co-cultured with exosomes from HemSCs transfected with miR-196b-5p mimic. In addition, apoptosis rate declined, and lower cells were arrested in G0/G1 phases. Cyclin E, bcl-2 were significantly highly expressed, whereas p27, Bax expression were significantly down-regulated. The positive effect of miR-196b-5p in HemSCs-exos was dramatically reversed when HemECs were transfected with oe-CDKN1B.
The current study found a novel intercellular interaction between IH cells. Briefly, exosome-derived miRNA-196b-5p in HemSCs could facilitate proliferation and angiogenesis abilities, and attenuate apoptosis and cell cycle repression rate of HemECs by directly binding with CDKN1B.
尽管婴儿血管瘤(IH)是一种常见的良性血管肿瘤,但其发病机制仍不清楚。本研究探讨了血管瘤来源的干细胞(HemSCs)衍生的外泌体的功能,其对血管瘤来源的内皮细胞(HemECs)发挥细胞间作用。
首先,提取并培养HemSCs和HemECs。收获HemSCs衍生的外泌体(HemSCs-exos)。使用miRNA测序和靶标预测来探索差异表达的miRNA和潜在的结合靶标。将HemECs与HemSCs-exos共培养后,进行一系列实验,包括细胞计数试剂盒-8(CCK-8)实验、细胞凋亡实验、细胞周期实验和管形成实验,以评估增殖、血管生成能力等。进行qRT-PCR和蛋白质免疫印迹检测靶基因和蛋白质的表达水平。
与HemSCs-exos共培养后,HemECs的增殖和血管生成能力增强,而凋亡和细胞周期停滞率降低。观察到miR-196b-5p在HemSCs-exos中显著高表达。CDKN1B被鉴定为miR-196b-5p的结合靶标。当与用miR-196b-5p模拟物转染的HemSCs的外泌体共培养时,HemECs的增殖和血管生成能力升高。此外,凋亡率下降,且较少细胞停滞在G0/G1期。细胞周期蛋白E、bcl-2显著高表达,而p27、Bax表达显著下调。当用oe-CDKN进行转染时,HemECs中miR-196b-5p在HemSCs-exos中的积极作用显著逆转。
当前研究发现了IH细胞之间一种新的细胞间相互作用。简而言之,HemSCs中来源于外泌体的miRNA-196b-5p可通过与CDKN1B直接结合促进HemECs的增殖和血管生成能力,并减弱其凋亡和细胞周期抑制率。